pages:
-
A Randomized Phase III Trial of Every-3-Weeks Paclitaxel Versus Dose Dense Weekly Paclitaxel in Combination with Carboplatin With or Without Concurrent and Consolidation Bevacizumab (NSC #704865, IND #7921) in the Treatment of Primary Stage III or IV Epithelial Ovarian, Peritoneal or Fallopian Tube Cancer
-
A Randomized Recruitment Intervention (RECRUIT)
-
A Randomized Recruitment Intervention (RECRUIT)
-
A Randomized Trial of Low Versus Moderate Exposure Busulfan for Infants with Severe Combined Immunodeficiency (SCID) Receiving TCRaß+/CD19+ Depleted Transplantation: A Phase II Study by the Primary Immune Deficiency Treatment Consortium (PIDTC) and Pediatric Blood and Marrow Transplant Consortium (PBMTC) PIDTC “CSIDE” Protocol (Conditioning SCID Infants Diagnosed Early) PBMTC NMD 1801
-
A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA)
-
A Randomized, Controlled Phase 1 Study of External Counterplusation as a Treatment for Acute Ischemic Stoke - (CUFFS)
-
A Randomized, Double-Blind, Phase I Dose-Escalation Study of the Novel Retinoid 9cUAB30
-
A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Lovastatin for Various Endpoints of Melanoma Pathobiology
-
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Doses of Aplindore MR (1, 3, and 6 mg Twice Daily) in Patients with Early Parkinson Disease
-
A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study To Assess The Safety, Tolerability, and Efficacy Of Oral Ketamine in Patients with Rett Syndrome
-
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease
-
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease
-
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two-Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants with Parkinson’s Disease (PD)
-
A Randomized, Double-Blind, Placebo-Controlled, Two Dose-Arm, Parallel Study of the Safety and Effectiveness of Immune Globulin Intravenous (Human), 10% (IGIV, 10%) for the Treatment of Mild-To-Moderate Alzheimer's Disease
-
A Randomized, Double-Blind, Single-Dose and Multi-Dose Study of the Novel Retinoid, 9cUAB30 to Determine Pharmacokinetics and Safety
-
A Randomized, Open Label, Multi-Center, Phase 3 Efficacy Study of Sub-Q Abatacept in Preventing Extension of Oligoarticular JIA (Limit-JIA)
-
A Randomized, Phase II Study Comparing Trastuzumab and Vinorelbine in Combination with Avelumab or Avelumab and Utomilumab (41BB/CD137 Agonist), In Patients with Her2-Positive
Metastatic Breast Cancer who have Progressed on Prior Trastuzumab and Pertuzumab:
The "AVIATOR” Study
-
A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment with Exenatide Once Weekly in Patients with Type 2 Diabetes Mellitus
-
A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment with Exenatide Once Weekly in Patients with Type 2 Diabetes Mellitus (EXSCEL)
-
A Rational Approach for HIV Vaccine T Cell Epitope Selection
-
A Reporter System to Monitor the Association of eRF1 and eRF3
-
A Review of Current Knowledge on the Safety of Gulf Seafood and Recommendations for Supplemental Testing
-
A Sex Difference Approach to Evaluating Resilience as a Predictor of Healthspan in Mice
-
A Simulation Model for Understanding Prevention and Treatment of Depression Among HIV+Women
-
A Simulation Model for Understanding Prevention and Treatment of Depression Among HIV+Women
-
A Sleep and Media Intervention to Improve Adolescents Weight and Risk of Type 2 Diabetes
-
A Sleep and Media Use Intervention to Improve Adolescents Weight and Risk of Cardiovascular Disease
-
A Specific Screening Strategy to Reduce Prostate Cancer Mortality
-
A Stakeholder-driven Comparative Effectiveness Study of Treatments to Prevent Coronary Artery Damage in Patients with Resistant Kawasaki Disease
-
A State of the Art Triple Quadruple Mass Spectrometer for pmol and fmol Analysis
pages:
